CareLit · DOI-Nachweis · Pneumologie
Nintedanib in patients with chronic fibrosing Interstitial lung diseases with progressive phenotype: the INBUILD trial*
DOI 10.1055/s-0039-3403297
Bibliografische Angaben
Nachweis in CareLit
Autor:innenD Koschel, KR Flaherty, AU Wells, V Cottin, A Devaraj, Y Inoue, L Richeldi, S Walsh, S Stowasser, C Coeck, RG Goeldner, E Clerisme-Beaty, R Schlenker-Herceg, KK Brown
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74
Kernaussage aus der Literatur
Abstract-Vorschau
Nintedanib in patients with chronic fibrosing Interstitial lung diseases with progressive phenotype: the INBUILD trial*
Zitieren
Zitierempfehlung
D Koschel, KR Flaherty, AU Wells, V Cottin, A Devaraj, Y Inoue, L Richeldi, S Walsh, S Stowasser, C Coeck, RG Goeldner, E Clerisme-Beaty, R Schlenker-Herceg, KK Brown (2020) Nintedanib in patients with chronic fibrosing Interstitial lung diseases with progressive phenotype: the INBUILD trial*. Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403297
Mit CareLit weiterarbeiten